CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.42 -0.15 (-4.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

CollPlant Biotechnologies (CLGN) Change in Accured Expenses (2018 - 2026)

Updated

CollPlant Biotechnologies (CLGN) reported Change in Accured Expenses of $323,000 for the quarter ended Jun 30, 2026, up 137.5% from $136,000 a year earlier.

Analysis

CollPlant Biotechnologies (CLGN) Change in Accured Expenses (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, CollPlant Biotechnologies' Change in Accured Expenses came in at $373,000; for the year ended Dec 31, 2025, it came in at -$46,000.

  • By year, Change in Accured Expenses came in at -$353,000 in the year ended Dec 31, 2024, $204,000 in the year ended Dec 31, 2023, $14,000 in the year ended Dec 31, 2022 and -$464,000 in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Change in Accured Expenses since the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 CollPlant Biotechnologies 4.38 Mn -25.06 Mn -456,000.00 323,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 323,000.00
Dec 31, 2025 22,000.00
Sep 30, 2025 -108,000.00
Jun 30, 2025 136,000.00
Dec 31, 2024 32,000.00
Sep 30, 2024 -52,000.00
Jun 30, 2024 -394,000.00
Mar 31, 2024 61,000.00
Dec 31, 2023 328,000.00
Sep 30, 2023 -102,000.00
Jun 30, 2023 -88,000.00
Mar 31, 2023 66,000.00
Dec 31, 2022 476,000.00
Sep 30, 2022 -157,000.00
Jun 30, 2022 28,000.00
Mar 31, 2022 -333,000.00
Dec 31, 2021 -464,000.00
Sep 30, 2021 -627,000.00
Jun 30, 2021 -80,000.00
Mar 31, 2021 -229,000.00
API Access

CollPlant Biotechnologies Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CLGN&period=max&api_key=YOUR_API_KEY